Get Involved Filling a Void A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers. by Elizabeth Rosto Sitko Despite Generic Imatinib, Cost of Treating CML Remains High The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds. by Anna Azvolinsky When Cancer Becomes an Unwanted Priority Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.” by Amanda Rose Ferraro Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Finding More Targets for CAR-T Cells CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy. by Kendall K. Morgan FROM THE EDITOR-IN-CHIEF Clonal Hematopoiesis: You Are Not the Same Person You Used to Be DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop. by William G. Nelson, MD, PhD FORWARD LOOK Pediatric Leukemia Treatments Are Not Just for Kids Study supports using these regimens for teens and young adults. by Bradley Jones FROM THE EDITOR-IN-CHIEF CAR-T Cells: ‘Bionic’ Immune Cells for Treating Cancer T cells are being rebuilt to kill cancer cells. by William G. Nelson, MD, PhD Predicting Acute Myeloid Leukemia Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed. by Anna Azvolinsky Challenges Remain for Kids With Cancer More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments. by Cameron Walker next Cancer Talk A Modern Family My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent. by Allison Rosen What is a Super Responder? Researchers are investigating why certain patients have an exceptional response to a particular drug. by Bradley Jones Why Are Early-Onset Cancers Rising? Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults. by Kate Yandell Treating Cancer Patients With COVID-19: A New York City Experience An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19. by Anna Azvolinsky More Posts